Site 1301

Barcelona 08036

1 studies enrolling now · 2 studies all time

What they study most

Giant Cell Arteritis, Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma

Studies at this site

• FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC — Recruiting now
• KPL-301 for Subjects With Giant Cell Arteritis — Completed